S&P 500   3,002.66 (+1.23%)
DOW   27,087.44 (+1.12%)
QQQ   193.95 (+1.50%)
AAPL   235.81 (-0.03%)
FB   189.69 (+3.50%)
MSFT   141.57 (+1.45%)
GOOGL   1,245.75 (+2.30%)
AMZN   1,774.87 (+2.21%)
NVDA   197.72 (+6.00%)
MU   46.47 (+3.59%)
BABA   175.42 (+2.49%)
TSLA   259.00 (+0.79%)
AMD   30.89 (+1.18%)
F   9.08 (+2.83%)
ACB   3.81 (+8.56%)
BAC   29.99 (+2.92%)
GILD   65.55 (+1.61%)
DIS   130.26 (+0.43%)
S&P 500   3,002.66 (+1.23%)
DOW   27,087.44 (+1.12%)
QQQ   193.95 (+1.50%)
AAPL   235.81 (-0.03%)
FB   189.69 (+3.50%)
MSFT   141.57 (+1.45%)
GOOGL   1,245.75 (+2.30%)
AMZN   1,774.87 (+2.21%)
NVDA   197.72 (+6.00%)
MU   46.47 (+3.59%)
BABA   175.42 (+2.49%)
TSLA   259.00 (+0.79%)
AMD   30.89 (+1.18%)
F   9.08 (+2.83%)
ACB   3.81 (+8.56%)
BAC   29.99 (+2.92%)
GILD   65.55 (+1.61%)
DIS   130.26 (+0.43%)
Log in

CELLECT BIOTECH/S News Headlines (NASDAQ:APOP)

$0.46
+0.03 (+6.99 %)
(As of 10/15/2019 02:26 PM ET)
Today's Range
$0.40
Now: $0.46
$0.49
50-Day Range
$0.41
MA: $0.49
$0.53
52-Week Range
$0.39
Now: $0.46
$6.01
Volume122,875 shs
Average Volume32,202 shs
Market Capitalization$5.15 million
P/E RatioN/A
Dividend YieldN/A
Beta1.82

Headlines

CELLECT BIOTECH/S (NASDAQ APOP) News Headlines

Source:
DateHeadline
Financial Contrast: Glaukos (NYSE:GKOS) versus CELLECT BIOTECH/S (NYSE:APOP)Financial Contrast: Glaukos (NYSE:GKOS) versus CELLECT BIOTECH/S (NYSE:APOP)
www.americanbankingnews.com - October 2 at 3:27 PM
BRIEF-Cellect Biotechnology Announces Positive Outcome From Safety Review CommitteeBRIEF-Cellect Biotechnology Announces Positive Outcome From Safety Review Committee
www.msn.com - August 13 at 5:35 AM
Mid-Afternoon Market Update: Dow Falls Over 350 Points; Cellect Biotechnology Shares SurgeMid-Afternoon Market Update: Dow Falls Over 350 Points; Cellect Biotechnology Shares Surge
www.benzinga.com - August 13 at 5:35 AM
Cellect Shares Rally After Lead Stem Cell Program Receives Clearance For Midstage StudyCellect Shares Rally After Lead Stem Cell Program Receives Clearance For Midstage Study
finance.yahoo.com - August 13 at 5:35 AM
Cellect Biotechnology Announces Positive Outcome From Safety Review Committee; Successfully Transplants 9th Clinical Trial PatientCellect Biotechnology Announces Positive Outcome From Safety Review Committee; Successfully Transplants 9th Clinical Trial Patient
finance.yahoo.com - August 12 at 9:23 AM
Cellect Biotechnology and Washington University (WU) Finalize Accelerated Clinical Trial AgreementCellect Biotechnology and Washington University (WU) Finalize Accelerated Clinical Trial Agreement
finance.yahoo.com - July 18 at 7:44 PM
Cellect Biotechnology Reports First Quarter 2019 Financial and Operating ResultsCellect Biotechnology Reports First Quarter 2019 Financial and Operating Results
finance.yahoo.com - May 21 at 11:37 AM
Cellect Biotechnology Announces Receipt of Nasdaq Minimum Bid Price NotificationCellect Biotechnology Announces Receipt of Nasdaq Minimum Bid Price Notification
finance.yahoo.com - May 16 at 9:40 AM
Cellect Biotechnology to Explore Strategic Alternatives to Maximize Shareholder ValueCellect Biotechnology to Explore Strategic Alternatives to Maximize Shareholder Value
finance.yahoo.com - May 16 at 9:40 AM
Cellect Announces Positive Phase I/II Mid-Study Results of Its ApoGraft™ TechnologyCellect Announces Positive Phase I/II Mid-Study Results of Its ApoGraft™ Technology
finance.yahoo.com - March 27 at 11:06 AM
Cellect Biotechnology Reports Fourth Quarter and Full Year 2018 Results and Recent Corporate ProgressCellect Biotechnology Reports Fourth Quarter and Full Year 2018 Results and Recent Corporate Progress
finance.yahoo.com - March 18 at 5:34 PM
Stem Cell Collaboration Results Push Cellect Biotechnology Shares Higher, Full AnalysisStem Cell Collaboration Results Push Cellect Biotechnology Shares Higher, Full Analysis
finance.yahoo.com - March 12 at 12:08 PM
Cellect Announces Positive Results From Cell2in Collaboration Showing Significant Improvement in Expansion Rate and Function of Stem CellsCellect Announces Positive Results From Cell2in Collaboration Showing Significant Improvement in Expansion Rate and Function of Stem Cells
finance.yahoo.com - March 11 at 8:02 AM
Cellect Announces Closing of $6.5 Million Underwritten Public OfferingCellect Announces Closing of $6.5 Million Underwritten Public Offering
finance.yahoo.com - February 13 at 5:23 PM
Cellect Announces Pricing of $6.5 Million Public OfferingCellect Announces Pricing of $6.5 Million Public Offering
finance.yahoo.com - February 8 at 9:48 AM
Cellect Begins Collaboration with Washington University in Preparation for First U.S. Clinical Trial Using Cellects ApoGraft™ for Bone Marrow TransplantationsCellect Begins Collaboration with Washington University in Preparation for First U.S. Clinical Trial Using Cellect's ApoGraft™ for Bone Marrow Transplantations
finance.yahoo.com - February 5 at 8:42 AM
Cellect Biotechnology Ltd. ADRCellect Biotechnology Ltd. ADR
www.barrons.com - January 28 at 5:06 PM
Completion of Manufacturing of Clinical Grade FasL Enables Cellect to Expedite U.S. Clinical Programs into Multiple StudiesCompletion of Manufacturing of Clinical Grade FasL Enables Cellect to Expedite U.S. Clinical Programs into Multiple Studies
finance.yahoo.com - January 28 at 10:00 AM
Cellect Biotechnology Reports Clinical and Regulatory Milestone TargetsCellect Biotechnology Reports Clinical and Regulatory Milestone Targets
finance.yahoo.com - January 23 at 9:30 AM
Further to the Announcement of the Agreement Signed With the South Korean Cell2in: KORIL Approves Cellects Grant ApplicationFurther to the Announcement of the Agreement Signed With the South Korean Cell2in: KORIL Approves Cellect's Grant Application
finance.yahoo.com - December 17 at 8:40 AM
Frost & Sullivan Publishes Q3-2018 Update On Cellect Biotechnology Ltd.Frost & Sullivan Publishes Q3-2018 Update On Cellect Biotechnology Ltd.
www.bizjournals.com - December 13 at 5:41 PM
Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial ResultsCellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results
finance.yahoo.com - November 13 at 8:11 AM
Cellect Receives Multiple Patent GrantsCellect Receives Multiple Patent Grants
finance.yahoo.com - November 5 at 10:12 AM
Cellect to Present Its Breakthrough Stem Cell Production Technology at the BIO-EuropeCellect to Present Its Breakthrough Stem Cell Production Technology at the BIO-Europe
finance.yahoo.com - November 1 at 8:23 AM
Cellect Announces a Major Technological Breakthrough for Industrialization of Apotainer™ Stem Cell Product LineCellect Announces a Major Technological Breakthrough for Industrialization of Apotainer™ Stem Cell Product Line
finance.yahoo.com - October 22 at 9:14 AM
Positive Results of Orthopedic Treatment With the Use of ApoGraft™ Enriched Stem Cells Derived From Fat TissuesPositive Results of Orthopedic Treatment With the Use of ApoGraft™ Enriched Stem Cells Derived From Fat Tissues
finance.yahoo.com - October 18 at 8:19 AM
Form 6-K Cellect Biotechnology For: Oct 15Form 6-K Cellect Biotechnology For: Oct 15
www.streetinsider.com - October 15 at 5:09 PM
Cellects ApoGraft shows encouraging action in early-stage study; shares up 1%Cellect's ApoGraft shows encouraging action in early-stage study; shares up 1%
seekingalpha.com - October 15 at 5:09 PM
Cellect Announces Positive Clinical ResultsCellect Announces Positive Clinical Results
finance.yahoo.com - October 15 at 8:28 AM
Cellect Receives Notice of Allowance for Stem Cell Selection Technology Patent in KoreaCellect Receives Notice of Allowance for Stem Cell Selection Technology Patent in Korea
finance.yahoo.com - October 9 at 5:07 PM
Cellect and Cell2in Launch Collaboration to Significantly Improve Stem Cell Selection and ExpansionCellect and Cell2in Launch Collaboration to Significantly Improve Stem Cell Selection and Expansion
finance.yahoo.com - August 13 at 8:55 AM
Cellect Biotechnology Provides Corporate Update and Reports Second Quarter 2018 Financial ResultsCellect Biotechnology Provides Corporate Update and Reports Second Quarter 2018 Financial Results
finance.yahoo.com - August 9 at 5:12 PM
Cellect Biotechnology (APOP) Granted Key European Patent for Its Stem Cell Selection TechnologyCellect Biotechnology (APOP) Granted Key European Patent for Its Stem Cell Selection Technology
www.streetinsider.com - August 7 at 8:48 AM
Cellect Granted Key European Patent for Its Stem Cell Selection TechnologyCellect Granted Key European Patent for Its Stem Cell Selection Technology
finance.yahoo.com - August 7 at 8:48 AM
Cellect Biotechnology (APOP) Announces Strategic Agreement with Swiss Biotech CenterCellect Biotechnology (APOP) Announces Strategic Agreement with Swiss Biotech Center
www.streetinsider.com - July 9 at 8:06 AM
Cellect Signed Strategic Agreement with Swiss Biotech Center (SBC)Cellect Signed Strategic Agreement with Swiss Biotech Center (SBC)
finance.yahoo.com - July 9 at 8:06 AM
Cellect Signs Collaboration Agreement With Dresden University denovoMATRIX TeamCellect Signs Collaboration Agreement With Dresden University denovoMATRIX Team
finance.yahoo.com - July 5 at 8:00 AM
Cellect Biotechnology reports Q1 resultsCellect Biotechnology reports Q1 results
seekingalpha.com - May 17 at 5:28 PM
Cellect Biotechnology Ltd Provides Corporate Update and Reports First Quarter 2018 Financial ResultsCellect Biotechnology Ltd Provides Corporate Update and Reports First Quarter 2018 Financial Results
finance.yahoo.com - May 17 at 5:22 PM
Former GE Healthcare Executive to Join Cellect as Chief Business OfficerFormer GE Healthcare Executive to Join Cellect as Chief Business Officer
finance.yahoo.com - May 10 at 8:41 AM
Cellect Bio up 21% premarket on advancement of new stem cell production techniqueCellect Bio up 21% premarket on advancement of new stem cell production technique
seekingalpha.com - April 9 at 9:04 AM
Cellect Announces a Major Milestone for Enabling Stem Cells ProductionCellect Announces a Major Milestone for Enabling Stem Cells Production
finance.yahoo.com - April 9 at 9:04 AM
Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial ResultsCellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - March 19 at 5:27 PM
Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the companys clinical and strategic goals; price target unchangedFrost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's clinical and strategic goals; price target unchanged
finance.yahoo.com - February 1 at 3:27 PM
Cellect Biotechnology Announces $4 Million Registered Direct OfferingCellect Biotechnology Announces $4 Million Registered Direct Offering
finance.yahoo.com - January 29 at 3:29 PM
Cellect Announces Opening of a Second Clinical Trial Site and Approval from Safety Board (DSMB) for Dose EscalationCellect Announces Opening of a Second Clinical Trial Site and Approval from Safety Board (DSMB) for Dose Escalation
finance.yahoo.com - January 16 at 10:46 AM
Cellect stock rockets 50% on ‘breakthrough’ trial announcement — but results are for just three patientsCellect stock rockets 50% on ‘breakthrough’ trial announcement — but results are for just three patients
finance.yahoo.com - January 4 at 4:13 PM
Cellect Announces Breakthrough Clinical ResultsCellect Announces Breakthrough Clinical Results
finance.yahoo.com - January 4 at 10:40 AM
UPDATE: Cellect Biotech shares rocket 79% premarket after unveiling stem cell breakthroughUPDATE: Cellect Biotech shares rocket 79% premarket after unveiling stem cell breakthrough
finance.yahoo.com - January 4 at 10:40 AM
Cellect Biotechnology Ltd Provides Corporate Update and Reports Third Quarter 2017 Financial ResultsCellect Biotechnology Ltd Provides Corporate Update and Reports Third Quarter 2017 Financial Results
www.prnewswire.com - November 22 at 7:37 AM
This page was last updated on 10/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel